Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

APRE holding history

Aprea Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APRE overviewAll 13F holders of APREFull Q4 2025 holdings

Shares (Q4 2025)
58,086
Value
$49.5K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of APRE by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202558,086$49.5K<0.1%−100,152−63.3%ReducedHolders
Q3 2025158,238$233.4K<0.1%−15,604−9.0%ReducedHolders
Q2 2025173,842$295.5K<0.1%00.0%UnchangedHolders
Q1 2025173,842$354.6K<0.1%00.0%UnchangedHolders
Q4 2024173,842$570.2K<0.1%00.0%UnchangedHolders
Q3 2024173,842$478.1K<0.1%+58,004+50.1%AddedHolders
Q2 2024115,838$471.5K<0.1%−140−0.1%ReducedHolders
Q1 2024115,978$775.9K<0.1%+81,290+234.3%AddedHolders
Q4 202334,688$163.0K<0.1%+7,347+26.9%AddedHolders
Q3 202327,341$113.9K<0.1%+11,840+76.4%AddedHolders
Q2 202315,501$48.8K<0.1%00.0%UnchangedHolders
Q1 202315,501$68.8K<0.1%00.0%UnchangedConverted for a 1-for-20 splitHolders
Q4 2022310,029$102.6K<0.1%+431+0.1%AddedHolders
Q3 2022309,598$201.0K<0.1%−45,892−12.9%ReducedHolders
Q2 2022355,490$266.0K<0.1%00.0%UnchangedHolders
Q1 2022355,490$662.0K<0.1%−341,336−49.0%ReducedHolders
Q4 2021696,826$2.00M<0.1%−20,589−2.9%ReducedHolders
Q3 2021717,415$3.67M<0.1%+9,993+1.4%AddedHolders
Q2 2021707,422$3.45M<0.1%−45,312−6.0%ReducedHolders
Q1 2021752,734$3.84M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.